Skip to main content

#Influenza and Other Respiratory Viruses Research #References (by AMEDEO, Feb. 16 '25)

 


    Am J Med

  1. SEELEY MC, Gallagher C, Ong E, Langdon A, et al
    High Incidence of Autonomic Dysfunction and Postural Orthostatic Tachycardia Syndrome in Patients with Long COVID: Implications for Management and Health Care Planning.
    Am J Med. 2025;138:354-361.
    PubMed         Abstract available

  2. MCLAUGHLIN M, Cerexhe L, Macdonald E, Ingram J, et al
    A Cross-Sectional Study of Symptom Prevalence, Frequency, Severity, and Impact of Long COVID in Scotland: Part II.
    Am J Med. 2025;138:330-336.
    PubMed         Abstract available

  3. LAU B, Wentz E, Ni Z, Yenokyan K, et al
    Physical Health and Mental Fatigue Disability Associated with Long COVID: Baseline Results from a US Nationwide Cohort.
    Am J Med. 2025;138:287-297.
    PubMed         Abstract available

  4. MCLAUGHLIN M, Sanal-Hayes NEM, Hayes LD, Berry EC, et al
    People with Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Exhibit Similarly Impaired Vascular Function.
    Am J Med. 2025;138:560-566.
    PubMed         Abstract available

  5. ZHENG C, Huang WY, Sun FH, Wong MC, et al
    Association of Sedentary Lifestyle with Risk of Acute and Post-Acute COVID-19 Sequelae: A Retrospective Cohort Study.
    Am J Med. 2025;138:298-307.
    PubMed         Abstract available

  6. LEE JS, Choi Y, Joung JY, Son CG, et al
    Clinical and Laboratory Characteristics of Fatigue-Dominant Long-COVID Subjects: A Cross-Sectional Study.
    Am J Med. 2025;138:346-353.
    PubMed         Abstract available

  7. BONNER-JACKSON A, Vangal R, Li Y, Thompson N, et al
    Factors Associated with Cognitive Impairment in Patients with Persisting Sequelae of COVID-19.
    Am J Med. 2025;138:337-345.
    PubMed         Abstract available

  8. HEJAZIAN SS, Sadr AV, Shahjouei S, Vemuri A, et al
    Prevalence and Determinants of Long-Term Post-COVID Conditions in the United States: 2022 Behavioral Risk Factor Surveillance System.
    Am J Med. 2025;138:513-523.
    PubMed         Abstract available

  9. ASHIQUE S, Mishra N, Garg A, Garg S, et al
    A Critical Review on the Long-term COVID-19 Impacts on Patients with Diabetes.
    Am J Med. 2024 Mar 12:S0002-9343(24)00133-5. doi: 10.1016/j.amjmed.2024.
    PubMed         Abstract available

  10. HOWICK V JF, Saric P, Elwazir M, Newman DB, et al
    A Pragmatic Study of Cardiovascular Disease During Long-Term COVID-19.
    Am J Med. 2024 Mar 26:S0002-9343(24)00162-1. doi: 10.1016/j.amjmed.2024.
    PubMed         Abstract available

  11. BENITO-LEON J, Lapena J, Garcia-Vasco L, Cuevas C, et al
    Exploring Cognitive Dysfunction in Long COVID Patients: Eye Movement Abnormalities and Frontal-Subcortical Circuits Implications via Eye-Tracking and Machine Learning.
    Am J Med. 2025;138:550-559.
    PubMed         Abstract available

  12. THAPALIYA K, Marshall-Gradisnik S, Eaton-Fitch N, Eftekhari Z, et al
    Imbalanced Brain Neurochemicals in long COVID and ME/CFS: A Preliminary Study using MRI.
    Am J Med. 2024 Apr 6:S0002-9343(24)00216-X. doi: 10.1016/j.amjmed.2024.
    PubMed         Abstract available

  13. PALAU P, Calvo B, Sastre C, Dominguez E, et al
    Unraveling the Mechanisms Behind Exercise Intolerance and Recovery in Long COVID.
    Am J Med. 2025;138:362-367.
    PubMed         Abstract available

  14. VELASQUEZ GARCIA HA, Wong S, Jeong D, Binka M, et al
    Risk of major adverse cardiovascular events after SARS-CoV-2 infection in British Columbia: a population-based study.
    Am J Med. 2024 Apr 24:S0002-9343(24)00237-7. doi: 10.1016/j.amjmed.2024.
    PubMed         Abstract available

  15. PAN D, Diaz JL, Weidman K, Graham J, et al
    Social Networks as a Key Health Determinant in Acute Illness Recovery: A Lesson from the COVID-19 Pandemic.
    Am J Med. 2025;138:541-549.
    PubMed         Abstract available

  16. DUNN J, Davis BR, Matarazzo A, Willett Y, et al
    New Clinical and Public Health Challenges in Vaccinations in US Adults.
    Am J Med. 2025;138:185-189.
    PubMed         Abstract available

  17. ULVI SAYGI AYVACI M, Jacobi VS, Ryu Y, Gundreddy SPS, et al
    Clinically Guided Adaptive Machine Learning Update Strategies for Predicting Severe COVID-19 Outcomes.
    Am J Med. 2025;138:228-235.
    PubMed         Abstract available


    Antimicrob Agents Chemother

  18. RODRIGUEZ L, Lee HW, Li J, Martin R, et al
    SARS-CoV-2 resistance analyses from the Phase 3 PINETREE study of remdesivir treatment in nonhospitalized participants.
    Antimicrob Agents Chemother. 2025;69:e0123824.
    PubMed         Abstract available


    Antiviral Res

  19. TIETJEN I, Kwan DC, Petrich A, Zell R, et al
    Antiviral Mechanisms and Preclinical Evaluation of Amantadine Analogs that Continue to Inhibit Influenza A Viruses with M2(S31N)-Based Drug Resistance.
    Antiviral Res. 2025 Feb 11:106104. doi: 10.1016/j.antiviral.2025.106104.
    PubMed         Abstract available


    Epidemiol Infect

  20. CAMPMAN SL, Boyd A, Schinkel J, Coyer L, et al
    SARS-CoV-2 infection and vaccination status in six ethnic groups in Amsterdam, The Netherlands, May to November 2022.
    Epidemiol Infect. 2025;153:e23.
    PubMed         Abstract available


    J Epidemiol Community Health

  21. WEISS D, Lowenstein C, Sund ER, Vethe D, et al
    Diverging mental health trends in the postpandemic era: results from the HUNT Study, Norway.
    J Epidemiol Community Health. 2025;79:165-168.
    PubMed         Abstract available

  22. ISLAM Z, Yamamoto S, Inoue Y, Honda T, et al
    Impact of the COVID-19 pandemic on the incidence of cardiometabolic risk factors among workers: results from the Japan Epidemiology Collaboration on Occupational Health study.
    J Epidemiol Community Health. 2025;79:193-199.
    PubMed         Abstract available


    J Gen Virol

  23. WEBB I, Erdmann M, Milligan R, Savage M, et al
    Examining the feasibility of replacing ORF3a with fluorescent genes to construct SARS-CoV-2 reporter viruses.
    J Gen Virol. 2025;106:002072.
    PubMed         Abstract available


    J Infect Dis

  24. GUEZALA MC, Schilling MA
    One Health Networks for Infectious Diseases Surveillance and Pandemic Preparedness in Central and South America.
    J Infect Dis. 2025;231.
    PubMed         Abstract available

  25. SOTO G, Romero C, Gonzales M, La Rosa S, et al
    Influenza Virus Surveillance in Healthcare Personnel in Peru: NAMRU SOUTH Experience and Perspective.
    J Infect Dis. 2025;231.
    PubMed         Abstract available


    J Virol

  26. KOBAYASHI D, Hiono T, Arakawa H, Kaji H, et al
    Deglycosylation and truncation in the neuraminidase stalk are functionally equivalent in enhancing the pathogenicity of a high pathogenicity avian influenza virus in chickens.
    J Virol. 2025 Feb 14:e0147824. doi: 10.1128/jvi.01478.
    PubMed         Abstract available


    JAMA

  27. JOHANSEN ND, Biering-Sorensen T
    Electronic Nudges for Influenza Vaccination-Reply.
    JAMA. 2025 Feb 10. doi: 10.1001/jama.2024.26535.
    PubMed        

  28. WU PH, Ho YY, Chang CM
    Electronic Nudges for Influenza Vaccination.
    JAMA. 2025 Feb 10. doi: 10.1001/jama.2024.26532.
    PubMed        


    MMWR Morb Mortal Wkly Rep

  29. LEONARD J, Harker EJ, Szablewski CM, Margrey SF, et al
    Notes from the Field: Seroprevalence of Highly Pathogenic Avian Influenza A(H5) Virus Infections Among Bovine Veterinary Practitioners - United States, September 2024.
    MMWR Morb Mortal Wkly Rep. 2025;74:50-52.
    PubMed        


    PLoS Comput Biol

  30. SIMPSON J, Kasson PM
    Structural prediction of chimeric immunogen candidates to elicit targeted antibodies against betacoronaviruses.
    PLoS Comput Biol. 2025;21:e1012812.
    PubMed         Abstract available

  31. LI W, Chen X, Liu S, Zhang C, et al
    Using a multi-strain infectious disease model with physical information neural networks to study the time dependence of SARS-CoV-2 variants of concern.
    PLoS Comput Biol. 2025;21:e1012778.
    PubMed         Abstract available


    PLoS One

  32. FARABI MNS, Mobin MA, Khan AN
    Assessing the efficacy of cash incentive policies in enhancing remittance inflows: Evidence from Bangladesh.
    PLoS One. 2025;20:e0318342.
    PubMed         Abstract available

  33. BRACKLEY D, Wells R
    The portrayal of panic-buying and stockpiling in English newspapers during Covid, a mixed-method content analysis.
    PLoS One. 2025;20:e0315142.
    PubMed         Abstract available

  34. INGLE L, Snook J, Smith L, Oliver B, et al
    Optimisation of the preparation phase for orthopaedic surgery: Study protocol for a student-led multimodal prehabilitation feasibility trial (BoneFit).
    PLoS One. 2025;20:e0314680.
    PubMed         Abstract available

  35. MERRITT BL, O'Neill DG, Brand CL, Belshaw Z, et al
    Lasting lockdown love? Problem behaviour and pandemic and non-pandemic related risk factors influencing the owner-dog relationship in a UK cohort of dogs reaching early adulthood.
    PLoS One. 2025;20:e0316166.
    PubMed         Abstract available

  36. DRYDEN-PETERSON S, Kim A, Caniglia EC, Joyce MR, et al
    Severe outcomes of COVID-19 among adults with increased risk conditions: A population-based observational study.
    PLoS One. 2025;20:e0316529.
    PubMed         Abstract available

  37. RUCHISRISAROD C, Wanthong P, Joyjinda Y, Bunprakob S, et al
    Antibodies response in symptomatic and asymptomatic SARS-CoV-2 infected persons in Thailand.
    PLoS One. 2025;20:e0308850.
    PubMed         Abstract available

  38. DUNDAR B
    A simulated annealing with graph-based search for the social-distancing problem in enclosed areas during pandemics.
    PLoS One. 2025;20:e0318380.
    PubMed         Abstract available

  39. MANZLI YS, Fakhfekh M, Bejaoui A, Alnafisah H, et al
    On the hedge and safe-haven abilities of bitcoin and gold against blue economy and green finance assets during global crises: Evidence from the DCC, ADCC and GO-GARCH models.
    PLoS One. 2025;20:e0317735.
    PubMed         Abstract available

  40. ASABA CN, Bitazar R, Labonte P, Bukong TN, et al
    Bronchoalveolar lavage single-cell transcriptomics reveals immune dysregulations driving COVID-19 severity.
    PLoS One. 2025;20:e0309880.
    PubMed         Abstract available

  41. MAMELI C, Valsecchi C, Cereda D, Scarioni S, et al
    Type 1 diabetes incidence during COVID-19 pandemic has not been influenced by COVID-19 vaccination in northern Italy region, Lombardy.
    PLoS One. 2025;20:e0316340.
    PubMed         Abstract available

  42. OELSNER EC, Krishnaswamy A, Rustamov R, Balte PP, et al
    Classifying COVID-19 hospitalizations in epidemiology cohort studies: The C4R study.
    PLoS One. 2025;20:e0316198.
    PubMed         Abstract available

  43. LIU T, Wang H, Liu Y, Li Z, et al
    Effect of organizational change on employee innovation performance: A dual mediation model.
    PLoS One. 2025;20:e0313056.
    PubMed         Abstract available

  44. LI Y, Tian X, Sun C, Wei Y, et al
    Outcome of COVID-19 in patients with idiopathic inflammatory myopathy during the Omicron wave in China: A longitudinal observational study.
    PLoS One. 2025;20:e0317319.
    PubMed         Abstract available

  45. ZHU S, Alam A, Thornhill R, Tsehmaister-Abitbul V, et al
    Impact of the COVID-19 pandemic on outcomes of acute ischemic stroke patients treated with endovascular therapy: A multicenter Canadian study.
    PLoS One. 2025;20:e0316734.
    PubMed         Abstract available

  46. SHEARD L, Previdoli G, Burton W, Benchekroun R, et al
    Fair food futures UK: Protocol for a mixed methods study exploring what approaches adopted by community food organisations are more likely to prevent the need for emergency food in two multicultural communities in Northern and Southern England.
    PLoS One. 2025;20:e0304917.
    PubMed         Abstract available

  47. GEBRETEKLE TK, Albers C
    Modelling the impact of behavioural interventions during pandemics: A systematic review.
    PLoS One. 2025;20:e0310611.
    PubMed         Abstract available

  48. GANTENBERG JR, van Aalst R, Diakun DR, Bengtson AM, et al
    Healthcare utilization during acute medically attended episodes of respiratory syncytial virus-related lower respiratory tract infection among infants in the United States.
    PLoS One. 2025;20:e0313573.
    PubMed         Abstract available

  49. LIU Y, Yu H, He J, Li J, et al
    The recombinant spike S1 protein induces injury and inflammation in co-cultures of human alveolar epithelial cells and macrophages.
    PLoS One. 2025;20:e0318881.
    PubMed         Abstract available

  50. GARREC C, Arrindell J, Andrieu J, Desnues B, et al
    Preferential apical infection of Caco-2 intestinal cell monolayers by SARS-CoV-2 is associated with damage to cellular barrier integrity: Implications for the pathophysiology of COVID-19.
    PLoS One. 2025;20:e0313068.
    PubMed         Abstract available

  51. BARKET SE, Karim MR, Salan MSA
    Bayesian spatio-temporal disease mapping of COVID-19 cases in Bangladesh.
    PLoS One. 2025;20:e0316621.
    PubMed         Abstract available

  52. MATH S, Nga JDL, Lim HF, Amin M, et al
    Teledentistry-Dental students' preparedness and patients' experiences.
    PLoS One. 2025;20:e0318991.
    PubMed         Abstract available

  53. NDAMUKUNDA ONU, Mutuyimana MT, Umubano F, Tuyishime E, et al
    Socioeconomic and academic consequences of COVID-19 pandemic on medical students from the University of Rwanda.
    PLoS One. 2025;20:e0318066.
    PubMed         Abstract available

  54. SKAMAGKI G, Blackburn L, Biggs D, Kolitsida M, et al
    Exploring burnout, perfectionism, and moral injury among UK physiotherapists: A qualitative study on professional fulfilment and well-being.
    PLoS One. 2025;20:e0313730.
    PubMed         Abstract available

  55. GU JM, Zhang SN, Xiao SY, Jia MY, et al
    Effect of Chinese herbal medicine (CHM) as an adjunctive therapy in distinct stages of patients with COVID-19: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0318892.
    PubMed         Abstract available

  56. KNIPE D, de Ossorno Garcia S, Salhi L, Afzal N, et al
    Digital mental health service engagement changes during Covid-19 in children and young people across the UK: Presenting concerns, service activity, and access by gender, ethnicity, and deprivation.
    PLoS One. 2025;20:e0316468.
    PubMed         Abstract available

  57. ISMAIL H, Huam ZS, Yew SQ, Ahmad H, et al
    Sickness absenteeism among nurses after the COVID-19 pandemic: A study protocol.
    PLoS One. 2025;20:e0314763.
    PubMed         Abstract available

  58. GELYI EK, Azaare J, Bonso NK, Kpordoxah MR, et al
    Impact of perceived factors of coronavirus infection on COVID-19 vaccine uptake among healthcare workers in Ghana-Evidence from a cross-sectional analysis.
    PLoS One. 2025;20:e0318662.
    PubMed         Abstract available

  59. LOVEDAY EK, Welhaven H, Erdogan AE, Hain KS, et al
    Starve a cold or feed a fever? Identifying cellular metabolic changes following infection and exposure to SARS-CoV-2.
    PLoS One. 2025;20:e0305065.
    PubMed         Abstract available

  60. LIU W, Liu C, Wang D, She Y, et al
    A novel framework for modeling quarantinable disease transmission.
    PLoS One. 2025;20:e0317553.
    PubMed         Abstract available

  61. KOSTINOV M, Chuchalin A, Chebykina A, Khrapunova I, et al
    Clinical status and cytokine profiles in patients with asthma or chronic obstructive pulmonary disease vaccinated against influenza.
    PLoS One. 2025;20:e0313539.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  62. NGUYEN YTK, Zhu X, Han J, Rodriguez AJ, et al
    Structural characterization of influenza group 1 chimeric hemagglutinins as broad vaccine immunogens.
    Proc Natl Acad Sci U S A. 2025;122:e2416628122.
    PubMed         Abstract available

  63. BRENNECKE B, Civili B, Sabale PM, Barluenga S, et al
    Self-assembled proteomimetic (SAP) with antibody-like binding from short PNA-peptide conjugates.
    Proc Natl Acad Sci U S A. 2025;122:e2412850122.
    PubMed         Abstract available


    Vaccine

  64. ABBAD A, Yueh J, Yellin T, Singh G, et al
    Co-administration of seasonal quadrivalent influenza and COVID-19 vaccines leads to enhanced immune responses to influenza virus and reduced immune responses to SARS-CoV-2 in naive mice.
    Vaccine. 2025;50:126825.
    PubMed         Abstract available

  65. FAUSTINI SE, Backhouse C, Duggal NA, Toellner KM, et al
    Time of day of vaccination does not influence antibody responses to pneumococcal and annual influenza vaccination in a cohort of healthy older adults.
    Vaccine. 2025;49:126770.
    PubMed         Abstract available

  66. O'KENNEDY MM, Reedy SE, Abolnik C, Khan A, et al
    Protective efficacy of a bivalent equine influenza H3N8 virus-like particle vaccine in horses.
    Vaccine. 2025;50:126861.
    PubMed         Abstract available

  67. WILLIAMS JTB, Johnson D, Weinshenker D, O'Leary ST, et al
    Co-creation of pediatric influenza digital stories via rapid community translation.
    Vaccine. 2025;51:126866.
    PubMed         Abstract available

  68. ESSINK BJ, Vermeulen W, Andrade C, de Rooij R, et al
    A randomised phase 2 immunogenicity and safety study of a MF59-adjuvanted quadrivalent subunit inactivated cell-derived influenza vaccine (aQIVc) in adults aged 50 years and older.
    Vaccine. 2025;51:126791.
    PubMed         Abstract available

  69. KIM SY, Song M, Kwon SL
    Impact of caregiver vaccination status on child influenza vaccination hesitancy: A time-to-vaccination analysis for 2023-2024 season in the Republic of Korea.
    Vaccine. 2025;49:126852.
    PubMed         Abstract available

  70. VAN DIEMEN PM, Lean FZX, Ramsay A, Mollett BC, et al
    Evaluation of a nanoparticle influenza vaccine in the pig model.
    Vaccine. 2025;49:126844.
    PubMed         Abstract available

Comments

Popular posts from this blog

#USA, APHIS Confirms {Avian #Influenza #H5N1} #D11 #Genotype in Dairy #Cattle in #Nevada

On January 31, 2025, the USDA Animal and Plant Health Inspection Service (APHIS) National Veterinary Services Laboratories (NVSL) confirmed by whole genome sequence the first detection of highly pathogenic avian influenza (HPAI) H5N1 clade 2.3.4.4b, genotype D1.1 in dairy cattle .  This confirmation was a result of State tracing and investigation, following an initial detection on silo testing under the USDA’s National Milk Testing Strategy (NMTS) in Nevada.  USDA APHIS continues to work with the Nevada Department of Agriculture by conducting additional on-farm investigation, testing, and gathering additional epidemiological information to better understand this detection and limit further disease spread.  This is the first detection of this virus genotype in dairy cattle (all previous detections in dairy cattle have been HPAI H5N1 clade 2.3.4.4b, genotype B3.13 ).  Genotype D1.1 represents the predominant genotype in the North American flyways this past fall an...

#USA, After #Birdflu Detected in Local #Cat, County #Health Officials Say #Pet Owners Should Contact Veterinarian When Their Pets are Sick

Redwood City — State veterinary and health officials have confirmed a case of H5N1 (bird flu) in a domestic stray cat in San Mateo County.  The infection, which is not related to the recent instance of bird flu in a backyard flock , was found in a stray cat in Half Moon Bay that had been taken in by a family .  When it showed symptoms, they took it to Peninsula Humane Society, whose veterinarians examined it and requested testing. Lab results confirmed H5N1.  It is not known how the cat was infected and it was euthanized due to its condition. Cats may be exposed to bird flu by consuming infected bird , being in environments contaminated with the virus and consuming unpasteurized milk from infected cows or raw food. Inside domestic animals, such as cats and dogs, that go outside are also at risk of infection.​​​​​​​ According to the Centers for Disease Control and Prevention, the risk of cats spreading H5N1 to people is extremely low, though it is possible for cats to spre...

#USA, Novel #Influenza A #H5N1 Virus: One Pediatric Case in #California {FluView}

 {Excerpt} One confirmed human infection with influenza A(H5) virus was reported to CDC this week. To date, human-to-human transmission of influenza A(H5) virus has not been identified in the United States. This case was reported by the California Department of Public Health and occurred in a child less than 18 years old with no known contact with influenza A(H5N1) virus-infected animals or humans . The investigation into the source of infection for this case is ongoing , and no human-to-human transmission has been identified. A specimen from the individual was tested at a public health laboratory using the CDC influenza A(H5) assay before being sent to CDC for further testing. The specimen was positive for influenza A(H5) virus using diagnostic RT-PCR at CDC. Additional analysis including genetic sequencing is underway. In response to this detection, additional case investigation and contact monitoring are being conducted by public health officials in California. There have now be...